Invention Grant
- Patent Title: Bacterial biomarker
-
Application No.: US17324899Application Date: 2021-05-19
-
Publication No.: US11376285B2Publication Date: 2022-07-05
- Inventor: Matthew Robinson , Trevor Lawley , Michael Romanos , Kevin Vervier , Simon Harris
- Applicant: Microbiotica Limited
- Applicant Address: GB Cambridge
- Assignee: Microbiotica Limited
- Current Assignee: Microbiotica Limited
- Current Assignee Address: GB Cambridge
- Agency: Myers Bigel, P.A.
- Priority: GB2007452 20200519
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A61K45/06 ; C07K16/28 ; C12N15/113 ; G01N33/483
Abstract:
The invention relates to bacterial compositions useful in the treatment of cancer. In particular, the compositions can be used as a co-therapy with an immune checkpoint therapy. The invention also relates to methods for identifying a subject that will respond to therapy with an immune checkpoint inhibitor comprising determining the abundance of bacteria in a biological sample from said subject.
Public/Granted literature
- US20210341458A1 Bacterial Biomarker Public/Granted day:2021-11-04
Information query
